Marsha M. Linehan, PhD, ABPP, the developer of Dialectical Behavior Therapy, is a Professor of Psychology and an adjunct Professor of Psychiatry at the University of Washington. She is also the Director of the Behavioral Research and Therapy Clinics, where she conducts research to develop and evaluate treatments for severe and complex mental disorders. She is the Founder of the Linehan Institute, Behavioral Tech, LLC, and Behavioral Tech Research. She has played a major role in the consultation, supervision, and training of mental health professionals around the world. DBT was celebrated by TIME in the book 100 New Scientific Discoveries. In 2016, the Association for Behavioral and Cognitive Therapies honored Dr. Linehan with a Career/Lifetime Achievement award.
Faculty Disclosure Statement:
Marsha M. Linehan, PhD, ABPP is the treatment developer of Dialectical Behavior Therapy (DBT). Her research clinic receives licensing fees for Behavioral Tech’s use of her materials. Dr. Linehan’s company (Behavioral Tech Research) owns the online training courses distributed by Behavioral Tech and Dr. Linehan receives royalties for use of the content she wrote for these products. She also receives royalties for her books on DBT and her research on DBT is funded by the US federal government.
Behavioral Tech Policies Regarding Faculty Disclosure and Disclaimers
Conflict of interest definition: A conflict of interest may be considered to exist if a continuing education course faculty is affiliated with, or has any significant financial interest, in any organization(s) that may have a direct interest in the subject matter of the presentation or may be co-sponsoring or offering financial support to the course. Situations involving a potential conflict of interest are not inherently bad or wrong, but in accordance with standards for continuing medical education we would like you to be aware of the affiliation/financial interest of your instructors.
Faculty Disclaimer: When an unlabelled use of a commercial product, or an investigative use not yet approved for any purpose is discussed during an educational activity, we shall require the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigative.
Notice of requirements for successful completion: For online training course, participants must complete the online course and all course materials to meet course completion requirements listed.
Commercial support or sponsorship: There is no commercial company support for this CME/CE event.
Noncommercial Sponsor Support: There is no noncommercial sponsor support for this CME/CE activity.
Non-Endorsement of Products: The Behavioral Tech approval status refers only to continuing education activities and does not imply that there is real or implied endorsement of any product, service, or company referred to in this activity nor of any company subsidizing costs related to the activity.
Off-Label Product Use: This CME/CE activity does not include any unannounced information about off-label use of a product for a purpose other than that for which it was approved by the Food and Drug Administration (FDA).
Disclosure of Relevant Financial Relationships: Faculty members are required to disclose all conflicts of interest and any relevant financial relationships that may affect the training content. Unless specified on Behavioral Tech’s website or on other printed materials/media, none of the individuals in a position to control the content of this CE/CME activity (including planners, editors, CE/CME Review Committee members, faculty presenters, moderators/facilitators, reviewers, etc.) have any relevant financial relationships to disclose.